Nitric oxide in allergic rhinitis and asthma

Area of Science:

• Immunology
• Respiratory Medicine
• Biochemistry

Background:

• Nitric oxide (NO) is a free radical with dual roles in nasal mucosa, sinuses, and airways, acting as both homeostatic and proinflammatory.
• Elevated NO levels are observed in various inflammatory airway conditions.

Purpose of the Study:

• To investigate the role of nitric oxide (NO) in inflammatory airway diseases.
• To assess the impact of therapeutic agents on NO levels in patients with these conditions.
• To determine if NO can serve as a biomarker for inflammation and therapy monitoring.

Main Methods:

• Measurement of nitric oxide (NO) levels in nasal fluid, serum, and mononuclear cells.
• Analysis of spontaneous and antigen-stimulated mononuclear cells.
• Evaluation of the effects of glucocorticoids, theophylline, and macrolides on NO levels.

Main Results:

• Patients with allergic rhinitis, sinusitis, and asthma exhibited elevated nitric oxide (NO) levels.
• Therapeutic agents including glucocorticoids, theophylline, and macrolides were shown to reduce NO levels in these patients.

Conclusions:

• Nitric oxide (NO) is implicated in the inflammatory processes of allergic rhinitis, sinusitis, and asthma.
• The reduction of NO levels by therapeutic agents suggests its potential as a biomarker.
• Monitoring NO production in nasal, serum, or airway samples may aid in evaluating anti-inflammatory therapies.